About Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc. (NYSE: CRL) is a Healthcare company (Medical - Diagnostics & Research) with a market capitalization of $17.0B. Its Maz Rating is 4.32 out of 5 (A, Strong Buy), ranked against the other companies in its sector.

Factor scores: Valuation 1.88, Growth 3.70, Profitability 4.63, Financial Health 2.02, Momentum 4.65 (as of 2026-10-16).

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Exchange

NYSE

Country

US

CEO

Birgit Girshick

Employees

19,000

IPO date

2000-06-23